Vonoprazan PCD Franchise in India: Why This Gastro Segment Is Worth a Closer Look in 2026
Gastro complaints are one of the few therapy categories in Indian pharma where demand almost never slows down — heartburn, acid reflux, and H. pylori-related ulcers are common across every season, every income bracket, and nearly every region. That steady baseline demand is exactly why a Vonoprazan PCD franchise has become one of the more talked-about opportunities in the gastro segment...